SCHEMBL3662881

SCHEMBL3662881

CCC=CCCOc1cccc(NC)c1F

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 3/20 0.33
PTPN1 P18031 1/20 0.33
APP P05067 1/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
HTR1B P28222 3/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C19 P33261 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
KMT2A Q03164 1/20 0.32
HTR1D P28221 1/20 0.31
ALDH1A1 P00352 2/20 0.31
CDK1 P06493 1/20 0.31
CCNB1 P14635 1/20 0.31
CCNA2 P20248 1/20 0.31
CDK2 P24941 1/20 0.31
CCNA1 P78396 1/20 0.31
LMNA P02545 1/20 0.31
MAPT P10636 1/20 0.31
PKM P14618 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3772711 1.00 EDNRA (0.33) EDNRAPTPN1APPL3MBTL1HTR1B
SCHEMBL3771932 0.93 L3MBTL1 (0.38) PTPN1APPL3MBTL1HTR1BCYP1A2
SCHEMBL3662847 0.93 L3MBTL1 (0.38) PTPN1APPL3MBTL1HTR1BCYP1A2
SCHEMBL3661806 0.92 L3MBTL1 (0.37) PTPN1APPL3MBTL1TDP1KMT2A
SCHEMBL3770873 0.92 L3MBTL1 (0.37) PTPN1APPL3MBTL1TDP1KMT2A
SCHEMBL3660391 0.91 PTPN1 (0.35) PTPN1APPL3MBTL1HTR1BCYP1A2
SCHEMBL3766152 0.91 PTPN1 (0.35) PTPN1APPL3MBTL1HTR1BCYP1A2
SCHEMBL3764580 0.89 PTPN1 (0.38) PTPN1L3MBTL1CYP1A2CYP2C19KMT2A
SCHEMBL3660872 0.89 PTPN1 (0.38) PTPN1L3MBTL1CYP1A2CYP2C19KMT2A
SCHEMBL3764832 0.87 APP (0.33) PTPN1APPL3MBTL1HTR1BTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHIEMCAL COMPANY LIMITED (JP) 2010-12-09 US disclosed
EP-2215062-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME Sumitomo Chemical Company, Limited (JP) 2010-08-11 EP disclosed
WO-2009069792-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-06-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100311790-A1 AMIDE COMPOUNDS AND PLANT DISEASE CONTROLLING METHOD USING SAME ATL3, NAT1, C5 EDNRA 1900/4885PTPN1 4208/4885APP 2380/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.